 Immunophenotyping
"Immunophenotyping" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.
| Descriptor ID |
D016130
|
| MeSH Number(s) |
E01.370.225.812.447 E05.200.812.447 E05.478.594.450
|
| Concept/Terms |
Immunophenotyping- Immunophenotyping
- Immunophenotypings
- Subtypings, Immunologic
- Subtyping, Immunologic
- Immunologic Subtyping
- Immunologic Subtypings
Lymphocyte Subtyping- Lymphocyte Subtyping
- Lymphocyte Subtypings
- Subtyping, Lymphocyte
- Subtypings, Lymphocyte
Lymphocyte Immunophenotyping- Lymphocyte Immunophenotyping
- Immunophenotyping, Lymphocyte
- Immunophenotypings, Lymphocyte
- Lymphocyte Immunophenotypings
- Lymphocyte Phenotyping
- Lymphocyte Phenotypings
- Phenotyping, Lymphocyte
- Phenotypings, Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Immunophenotyping".
Below are MeSH descriptors whose meaning is more specific than "Immunophenotyping".
This graph shows the total number of publications written about "Immunophenotyping" by people in this website by year, and whether "Immunophenotyping" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 2 | 2 | | 1993 | 0 | 2 | 2 | | 1994 | 0 | 1 | 1 | | 1995 | 0 | 5 | 5 | | 1996 | 0 | 4 | 4 | | 1997 | 0 | 5 | 5 | | 1998 | 0 | 5 | 5 | | 1999 | 0 | 8 | 8 | | 2000 | 0 | 5 | 5 | | 2001 | 0 | 6 | 6 | | 2002 | 1 | 4 | 5 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 9 | 9 | | 2005 | 0 | 3 | 3 | | 2006 | 0 | 3 | 3 | | 2007 | 0 | 4 | 4 | | 2008 | 1 | 8 | 9 | | 2009 | 0 | 3 | 3 | | 2011 | 0 | 6 | 6 | | 2012 | 1 | 5 | 6 | | 2013 | 0 | 5 | 5 | | 2014 | 1 | 6 | 7 | | 2015 | 0 | 7 | 7 | | 2016 | 0 | 4 | 4 | | 2017 | 0 | 4 | 4 | | 2018 | 1 | 2 | 3 | | 2019 | 0 | 2 | 2 | | 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunophenotyping" by people in Profiles.
-
Spurgeon BEJ, Linden MD, Michelson AD, Frelinger AL. Immunophenotypic Analysis of Platelets by Flow Cytometry. Curr Protoc. 2021 Jun; 1(6):e178.
-
Müller K, Honcharova-Biletska H, Koppe C, Egger M, Chan LK, Schneider AT, Küsgens L, Böhm F, Boege Y, Healy ME, Schmitt J, Comtesse S, Castoldi M, Preisinger C, Szydlowska M, Focaccia E, Gaisa NT, Loosen SH, Jörs S, Tacke F, Roderburg C, Keitel V, Bode JG, Boor P, Davis RJ, Longerich T, Geisler F, Heikenwalder M, Weber A, Vucur M, Luedde T. JNK signaling prevents biliary cyst formation through a CASPASE-8-dependent function of RIPK1 during aging. Proc Natl Acad Sci U S A. 2021 03 23; 118(12).
-
Jarjour NN, Schwarzkopf EA, Bradstreet TR, Shchukina I, Lin CC, Huang SC, Lai CW, Cook ME, Taneja R, Stappenbeck TS, Randolph GJ, Artyomov MN, Urban JF, Edelson BT. Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and type 2 immunity. Nat Immunol. 2019 06; 20(6):687-700.
-
Xia D, Morgan EA, Berger D, Pinkus GS, Ferry JA, Zukerberg LR. NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review. Am J Clin Pathol. 2019 01 01; 151(1):75-85.
-
Li S, Bostick JW, Ye J, Qiu J, Zhang B, Urban JF, Avram D, Zhou L. Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function. Immunity. 2018 11 20; 49(5):915-928.e5.
-
Zou Y, Qi Z, Guo W, Zhang L, Ruscetti M, Shenoy T, Liu N, Wu H. Cotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3Ka/ß/d Inhibitor BAY1082439. Mol Cancer Ther. 2018 10; 17(10):2091-2099.
-
Keegan A, Charest K, Schmidt R, Briggs D, Deangelo DJ, Li B, Morgan EA, Pozdnyakova O. Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease. J Clin Pathol. 2018 Jul; 71(7):653-658.
-
Sander J, Schmidt SV, Cirovic B, McGovern N, Papantonopoulou O, Hardt AL, Aschenbrenner AC, Kreer C, Quast T, Xu AM, Schmidleithner LM, Theis H, Thi Huong LD, Sumatoh HRB, Lauterbach MAR, Schulte-Schrepping J, Günther P, Xue J, Baßler K, Ulas T, Klee K, Katzmarski N, Herresthal S, Krebs W, Martin B, Latz E, Händler K, Kraut M, Kolanus W, Beyer M, Falk CS, Wiegmann B, Burgdorf S, Melosh NA, Newell EW, Ginhoux F, Schlitzer A, Schultze JL. Cellular Differentiation of Human Monocytes Is Regulated by Time-Dependent Interleukin-4 Signaling and the Transcriptional Regulator NCOR2. Immunity. 2017 12 19; 47(6):1051-1066.e12.
-
Dorfman DM, Morgan EA, Pelton A, Unitt C. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation. Hum Pathol. 2017 07; 65:166-174.
-
Cortazar JM, DeAngelo DJ, Pinkus GS, Morgan EA. Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissues. Histopathology. 2017 Jul; 71(1):112-124.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|